Anti-Human CD248 Recombinant Antibody

Name: Anti-Human CD248 Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1332

YR1332

科研级 Ontuxizumab ( 昂妥昔珠单抗 ), Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab

DATASHEET MSDS

Product Description

Alias	科研级 Ontuxizumab ( 昂妥昔珠单抗 ), Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab
Catalog Number	YR1332
Molecular Name	Ontuxizumab
Host	Mouse
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Ontuxizumab is a humanized rabbit monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1 or CD248). Phase I trials are complete and the drug was granted orphan drug status by the FDA for sarcoma. It is currently in phase II trials for melanoma, colorectal cancer, sarcoma, and lymphoma. This drug was developed by Morphotek and Ludwig Institute for Cancer Research.
CAS Number	946415-62-9
Application	Neut, ELISA, IF, IP, FuncS, FCM, ICC
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD248[Homo sapiens]

Login